Clinical Trial Update: Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pulmonary vasodilation effects on ventricle–arterial coupling in Fontan patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Single-ventricle Heart Disease

Snippet

Sponsor: University of California, San Francisco | Conditions: Congenital Heart Disease, Fontan | Phase 3 | Status: WITHDRAWN